Role of fibrinogen, albumin and fibrinogen to albumin ratio in determining angiographic severity and outcomes in acute coronary syndrome
CONCLUSION: Novel biomarkers, with their high cost, lack of availability and long turn over time are impractical for real-world use. Identifying ≤ TIMI 1 flow in the culprit artery has significant impact of management and outcome. Our study has shown that readily available biomarkers like fibrinogen and albumin can help identify these high-risk patients with good accuracy. This allows risk-stratification and individualization of treatment in ACS.PMID:36714367 | PMC:PMC9850671 | DOI:10.4330/wjc.v15.i1.13
Source: World Journal of Cardiology - Category: Cardiology Authors: Kunaal Makkar Yash Paul Sharma Akash Batta Juniali Hatwal Prashant Kumar Panda Source Type: research
More News: Angiography | Autoimmune Disease | Cancer & Oncology | Cardiology | Cardiovascular | Coronavirus | COVID-19 | Emergency Medicine | Heart | Heart Attack | Liver | Liver Disease | Pandemics | Study | Urology & Nephrology